CYCC · Categories · Form 4

CYCC - SEC Form 4 insider transactions

Cyclacel Pharmaceuticals Inc. (CYCC) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for CYCC

• 228d
  Large owner Kua Khai Loon sold $133,569 worth of shares (19,054 units at $7.01), decreasing direct ownership by 5% to 385,411 units (SEC Form 4)

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 234d
  Large owner Ong Yee Lung acquired 186,465 shares, increasing direct ownership by 86% to 404,465 units (SEC Form 4)

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 234d
  Large owner Yap Kim Choy acquired 186,465 shares, increasing direct ownership by 86% to 404,465 units (SEC Form 4)

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 234d
  Large owner Kua Khai Loon acquired 186,465 shares, increasing direct ownership by 86% to 404,465 units (SEC Form 4)

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 265d
  Large owner Lazar David E. sold $83,430 worth of shares (6,750 units at $12.36), decreasing direct ownership by 4% to 155,838 units (SEC Form 4)

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 422d
  SEC Form 4 filed by Director Natan David

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 422d
  Interim CEO Lazar David E. converted options into 194,628,820 shares and sold $5,507,996 worth of shares (194,628,820 units at $0.03) (SEC Form 4)

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 422d
  SEC Form 4 filed by Director Ben-Tzvi Avraham

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 440d
  SEC Form 4 filed by Interim CEO Lazar David E.

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 474d
  Director Natan David was granted 100,000 shares (SEC Form 4)

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 816d
  Schwartz Brian was granted 12,500 shares, increasing direct ownership by 462% to 15,205 units (SEC Form 4)

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1028d
  SEC Form 4 filed by Rombotis Spiro George

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1028d
  SEC Form 4 filed by Barker Sam L

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1028d
  SEC Form 4 filed by Spiegel Robert J.

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1028d
  SEC Form 4 filed by Mcbarron Paul

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1028d
  SEC Form 4 filed by Kirschbaum Mark

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1028d
  SEC Form 4 filed by Walker Karin L

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1028d
  SEC Form 4 filed by Ferguson Kenneth M.

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1028d
  SEC Form 4 filed by Henney Christopher S

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1028d
  SEC Form 4 filed by Schwartz Brian

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1179d
  SEC Form 4: Mcbarron Paul was granted 31,200 shares, increasing direct ownership by 10,685% to 31,492 units

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1179d
  SEC Form 4: Rombotis Spiro George was granted 57,600 shares, increasing direct ownership by 1,155% to 62,588 units

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1179d
  SEC Form 4: Kirschbaum Mark was granted 31,200 shares

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1409d
  SEC Form 4: Ferguson Kenneth M. was granted 23,733 shares (Amendment)

  4/A - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1410d
  SEC Form 4: Ferguson Kenneth M. was granted 27,733 shares

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1410d
  SEC Form 4: Walker Karin L was granted 15,822 shares, increasing direct ownership by 444% to 19,383 units

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1410d
  SEC Form 4: Spiegel Robert J. was granted 15,822 shares, increasing direct ownership by 666% to 18,196 units

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1410d
  SEC Form 4: Sems Lloyd was granted 15,822 shares, increasing direct ownership by 666% to 18,196 units

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1410d
  SEC Form 4: Schwartz Brian was granted 15,822 shares, increasing direct ownership by 444% to 19,383 units

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1410d
  SEC Form 4: Henney Christopher S was granted 15,822 shares, increasing direct ownership by 666% to 18,196 units

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1410d
  SEC Form 4: Barker Sam L was granted 15,822 shares, increasing direct ownership by 469% to 19,196 units

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1592d
  SEC Form 4 filed by Rombotis Spiro George (Amendment)

  4/A - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1593d
  SEC Form 4 filed by Rombotis Spiro George

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1593d
  SEC Form 4 filed by Mcbarron Paul

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1593d
  SEC Form 4 filed by Kirschbaum Mark

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1606d
  SEC Form 4: Barker Sam L sold $43 worth of shares (12 units at $3.57), decreasing direct ownership by 0.35% to 3,374 units

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1616d
  SEC Form 4: Rombotis Spiro George bought $18,000 worth of shares (4,000 units at $4.50), increasing direct ownership by 405% to 4,988 units

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1705d
  SEC Form 4: Barker Sam L bought $5,000 worth of Common Stock (1,000 units at $5.00), increasing direct ownership by 42% to 3,386 units

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1774d
  SEC Form 4: Hradsky Gregory T. was granted 2,374 units of Common Stock

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1774d
  SEC Form 4: HENNEY CHRISTOPHER S was granted 2,374 units of Common Stock

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1774d
  SEC Form 4: Spiegel Robert J. was granted 2,374 units of Common Stock

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1774d
  SEC Form 4: BARKER SAM L was granted 2,374 units of Common Stock, increasing direct ownership by 19,783% to 2,386 units

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1774d
  SEC Form 4: Sems Lloyd was granted 2,374 units of Common Stock

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1774d
  SEC Form 4: Walker Karin L was granted 3,561 units of Common Stock, increasing direct ownership by 200% to 3,561 units

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)
• 1774d
  SEC Form 4: SCHWARTZ BRIAN was granted 3,561 units of Common Stock, increasing direct ownership by 200% to 3,561 units

  4 - Cyclacel Pharmaceuticals, Inc. (0001130166) (Issuer)

Other CYCC categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends